drugset / Trial / NCT01909427
An Efficacy And Safety Study of CNTO 6785 In Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the efficacy and safety of CNTO6785 in participants with active rheumatoid arthritis (RA) despite methotrexate (MTX) therapy.
Timeline
- Start
- 2013-06
- Primary completion
- 2014-12
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CNTO 6785 | Monoclonal antibody | 15 mg | Subcutaneous |
| Subject | CNTO 6785 | Monoclonal antibody | 50 mg | Subcutaneous |
| Subject | CNTO 6785 | Monoclonal antibody | 100 mg | Subcutaneous |
| Subject | CNTO 6785 | Monoclonal antibody | 200 mg | Subcutaneous |
| Background | Methotrexate | Small molecule | — | — |